Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tecfidera”

111 trials

Showing 20 of 111 results

Post-approval studies (Phase 4)Study completedNCT02410278
What this trial is testing

Study of Montelukast on Gastrointestinal Tolerability in Patients With Relapsing Forms of Multiple Sclerosis Receiving Tecfidera

Who this might be right for
Multiple Sclerosis
Biogen 102
Large-scale testing (Phase 3)Study completedNCT02525874
What this trial is testing

Effect of BG00012 on Lymphocyte Subsets and Immunoglobulins in Subjects With Relapsing Remitting Multiple Sclerosis (RRMS).

Who this might be right for
Multiple Sclerosis, Relapsing-RemittingMultiple Sclerosis
Biogen 218
Testing effectiveness (Phase 2)Study completedNCT00810836
What this trial is testing

Efficacy and Safety Study of BG00012 With Methotrexate in Patients With Active Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Biogen 153
Not applicableStudy completedNCT05366036
What this trial is testing

Tecfidera (Dimethyl Fumarate) Capsules in Korean Participants With Relapsing-Remitting Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, Relapsing-remitting
Eisai Korea Inc. 172
Early research (Phase 1)Study completedNCT00837785
What this trial is testing

A 24-Hour Pharmacokinetic Determination of BG00012 After Single-Day Oral Administration in Subjects With MS

Who this might be right for
Relapsing Remitting Multiple Sclerosis
Biogen 48
Not applicableUnknownNCT04676204
What this trial is testing

Relationship Between Oral DMT Burden and Adherence in MS

Who this might be right for
Multiple SclerosisAdherence, Medication
Monash University 323
Not applicableStudy completedNCT03284970
What this trial is testing

Retrospective Study to Determine Effect of Rebif and Tecfidera on Infections and Lymphocytes

Who this might be right for
Relapsing-Remitting Multiple Sclerosis
EMD Serono Research & Development Institute, Inc. 34
Post-approval studies (Phase 4)Study completedNCT02125604
What this trial is testing

Gastrointestinal Tolerability Study Of Dimethyl Fumarate In Participants With Relapsing-Remitting Multiple Sclerosis In Germany

Who this might be right for
Relapsing-Remitting Multiple Sclerosis
Biogen 214
Post-approval studies (Phase 4)WithdrawnNCT02675413
What this trial is testing

Mechanisms of Action of Dimethyl Fumarate (Tecfidera) in Relapsing MS

Who this might be right for
Multiple SclerosisMultiple Sclerosis, Relapsing-Remitting
Washington University School of Medicine
Large-scale testing (Phase 3)Study completedNCT03255382
What this trial is testing

Assess the Efficacy of Risankizumab Compared to FUMADERM® in Subjects With Moderate to Severe Plaque Psoriasis Who Are Naïve to and Candidates for Systemic Therapy

Who this might be right for
Psoriasis
AbbVie 120
Post-approval studies (Phase 4)Ended earlyNCT02901106
What this trial is testing

Monitoring of Patients Followed for a Multiple Sclerosis and Treated by Dimethyl-fumarate

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Fondation Ophtalmologique Adolphe de Rothschild 11
Early research (Phase 1)Study completedNCT02955693
What this trial is testing

Study of the Effects of the Organism on Monomethyl Fumarate (MMF) After the Administration of LAS41008

Who this might be right for
Psoriasis
Almirall, S.A. 32
Large-scale testing (Phase 3)Study completedNCT02951533
What this trial is testing

Compare the Efficacy of Guselkumab to Fumaric Acid Esters for the Treatment of Participants With Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Janssen-Cilag G.m.b.H 119
Not applicableStudy completedNCT04834401
What this trial is testing

Effect of Disease Modifying Therapy on Antibody Response to COVID19 Vaccination in Multiple Sclerosis

Who this might be right for
Multiple SclerosisCovid19
St. Barnabas Medical Center 45
Testing effectiveness (Phase 2)Ended earlyNCT02975349
What this trial is testing

Efficacy and Safety of M2951 in Participants With Relapsing Multiple Sclerosis

Who this might be right for
Relapsing-remitting Multiple Sclerosis
EMD Serono Research & Development Institute, Inc. 267
Not applicableEnded earlyNCT02218879
What this trial is testing

Restoring Glutathione Synthesis With Tecfidera: An in Vivo H-MRS Single-Arm Study at 7T in Patients With RR MS

Who this might be right for
Multiple Sclerosis
Yale University 7
Early research (Phase 1)Study completedNCT04022473
What this trial is testing

Study to Compare GI Tolerability Following Oral Administration of Bafiertam™ or Tecfidera to Healthy Volunteers

Who this might be right for
Multiple Sclerosis
Banner Life Sciences LLC 210
Large-scale testing (Phase 3)Study completedNCT02283853
What this trial is testing

Phase 3 Efficacy and Safety Study of BG00012 in Pediatric Participants With Relapsing-Remitting Multiple Sclerosis (RRMS)

Who this might be right for
Relapsing-Remitting Multiple Sclerosis
Biogen 156
Not applicableStudy completedNCT03526224
What this trial is testing

Teriflunomide Tecfidera LMCE

Who this might be right for
TecfideraTeriflunomide
University at Buffalo 120
Early research (Phase 1)Study completedNCT01069913
What this trial is testing

Pharmacokinetics Profile Study of BG00012 Standard Formulation and BG00012 Active Pharmaceutical Ingredient

Who this might be right for
Healthy
Biogen 14
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation